Your browser doesn't support javascript.
loading
Influenza returns with a season dominated by clade 3C.2a1b.2a.2 A(H3N2) viruses, WHO European Region, 2021/22.
Melidou, Angeliki; Ködmön, Csaba; Nahapetyan, Karen; Kraus, Annette; Alm, Erik; Adlhoch, Cornelia; Mooks, Piers; Dave, Nishi; Carvalho, Carlos; Meslé, Margaux Mi; Daniels, Rodney; Pebody, Richard.
Afiliação
  • Melidou A; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Ködmön C; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Nahapetyan K; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
  • Kraus A; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Alm E; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Adlhoch C; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Mooks P; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
  • Dave N; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Carvalho C; European Centre for Disease Prevention and Control (ECDC), Stockholm, Sweden.
  • Meslé MM; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
  • Daniels R; WHO Collaborating Centre, Francis Crick Institute, London, United Kingdom.
  • Pebody R; World Health Organization (WHO) Regional Office for Europe, Copenhagen, Denmark.
Euro Surveill ; 27(15)2022 04.
Article em En | MEDLINE | ID: mdl-35426364
ABSTRACT
In the WHO European Region, COVID-19 non-pharmaceutical interventions continued slowing influenza circulation in the 2021/22 season, with reduced characterisation data. A(H3) predominated and, in some countries, co-circulated with A(H1)pdm09 and B/Victoria viruses. No B/Yamagata virus detections were confirmed. Substantial proportions of characterised circulating virus subtypes or lineages differed antigenically from their respective northern hemisphere vaccine components. Appropriate levels of influenza virus characterisations should be maintained until the season end and in future seasons, when surveillance is adapted to integrate SARS-CoV-2.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra Influenza / Influenza Humana / COVID-19 Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article